SternaLock Blu Proves It

Recovery Matters

Sternal stability and healing plays a key role in improving patient recovery. The SternaLock Blu Study examined numerous patient outcomes, including postoperative sternal pain, patient function, quality of life and outpatient and other resource utilization over a six-month period following cardiac surgery.

Patients treated with SternaLock Blu were found to have less pain, improved function and quality of life and spent less time in rehab hospitals and skilled nursing facilities. Within the 1st 3 months of surgery, there were significantly more patients with SternaLock Blu with no sternal pain compared to patients treated with wire cerclage.

Similar improvements were also seen in patient’s quality of life, and SternaLock Blu patients spent 237 total fewer days in rehab hospitals and skilled nursing facilities.

The SternaLock Blu Study also demonstrated a strong correlation between sternal healing and the absence of postoperative sternal pain, supporting that the improved stability and healing with
SternaLock Blu led to improved clinical outcomes and less postoperative pain.

Information presented is a summary of study results and should not be construed as a substitute for reviewing the actual study itself. All results are comparisons to wire closure. 1,2,3

Patients treated with SternaLock Blu experienced less pain, improved quality of life and spent fewer days in rehab hospitals and skilled nursing facilities.

Patients treated with SternaLock Blu spent fewer days in rehab hospitals or skilled nursing facilities.1,2,3

Contact Us

  • This field is for validation purposes and should be left unchanged.

Market Access Disclaimer

The cost or savings amounts reflected in the SternaLock® Blu Rigid Sternal Fixation Cost/Savings Model are based on the clinical and economic results and assumptions from the SternaLock® Blu Study1 as well as the model inputs selected and/or entered in the Model Inputs section. All content in this document is informational only, general in nature and does not cover all situations or all payers’ rules or policies. The service and the product must be reasonable and necessary for the care of the patient to support reimbursement. Providers should report the procedure and related codes that most accurately describe the patients’ medical condition, procedures performed and the products used. This document represents no promise or guarantee by Zimmer Biomet regarding coverage or payment for products or procedures by Medicare or other payers, nor concerning levels of costs or savings. Providers should check Medicare bulletins, manuals, program memoranda, and Medicare guidelines to ensure compliance with Medicare requirements. Inquiries can be directed to the provider’s respective Medicare Administrative Contractor, or to the respective Payers. Zimmer Biomet specifically disclaims liability or responsibility for the results or consequences of any actions taken in reliance on information in this guide.